Nav: Home

Vascularized kidney tissue engineered by WFIRM scientists

May 22, 2019

WINSTON-SALEM, NC, May 22, 2019 - Wake Forest Institute for Regenerative Medicine (WFIRM) researchers have shown the feasibility of bioengineering vascularized functional renal tissues for kidney regeneration, developing a partial augmentation strategy that may be a more feasible and practical approach than creating whole organs.

In the proof-of-concept study published online this month in Acta Biomaterialia journal, the scientists created a novel biomimetic, collagen-based vascular scaffold - a mold - that is structurally identical to native kidney tissue that was able to develop vascularized tissue.

"The use of this scaffold system could address the challenges associated with vascularization and may be an ideal treatment strategy for augmentation of renal function in patients with chronic kidney disease," said James Yoo, M.D., Ph.D., lead author and professor of regenerative medicine at WFIRM. "Vascularization continues to be one of the major hurdles affecting the survival and integration of implanted 3D tissue constructs."

In the United States, chronic kidney disease is prevalent, affecting more than 700,000 patients living with end stage renal disease. Although dialysis has supported the survival of patients with end stage renal disease, kidney transplantation remains the only definitive treatment. However, there are currently nearly 100,000 people on the waiting list, with nearly 9,000 patients being removed yearly due to deteriorating medical condition or death, which reflects the current state of ongoing organ shortage.

The limitations of current therapies for end stage renal disease led WFIRM researchers to explore the development of renal 3D constructs with the goal of improving, restoring, or replacing partial or total renal function.

"A universal challenge in engineering large solid organs is the need for vascularization," said Anthony Atala, M.D., a co-author of the paper and director of WFIRM. "Kidneys depend on complex 3D vascular networks for tissue survival and renal function, but the intricate nature of the renal vasculature makes replication difficult."

In order to treat chronic kidney disease, the WFIRM researchers knew they needed to address the feasibility of applying their vascular scaffold in the context of partial renal implantation. They have shown that the vascular scaffolds can be perfused and endothelialized in the lab, but the question of integration and functionality in a clinical model remained.

Various materials and combinations of collagen hydrogel, endothelial cells and renal cells were tested. Using polycaprolactone (PCL) solution and collagen as the casting and scaffold materials, respectively, the scientists essentially made molds using donor kidneys as templates, creating hollow scaffolds that were cultured in renal growth medium before implantation into the preclinical model. The level of neovascularization, survival of implanted human renal cells, and renal structure formation was evaluated.

The renal vascular scaffold showed a 3D branching architecture with visible hollow channels that were interconnected and continuous. These branching structures were able to allow perfusion similar to native blood vessels. The researchers showed that the vascular scaffolds integrated with the host vessels and supported renal cell viability.

"The biomimetic vascular scaffold coated with endothelial cells showed significantly enhanced vascularization, as compared to the uncoated scaffold and hydrogel only groups," Yoo said. "Along with the improved vascularization effects, the endothelial cell-coated scaffolds showed a significant renal cell infiltration from the neighboring host tissue, as compared to the other groups."

The results are promising and support continued exploration of this method to further evaluate renal function of the implanted constructs and address limitations such as improving systemic renal function.

"Overall, we are very pleased with the outcomes thus far," Atala said. "Further work is necessary to establish a reliable and reproducible system for clinical translation."
Co-authors include: Jennifer Huling, Sang-il Min, Doo Sang Kim and In Kap Ko, all of WFIRM.

This study was supported by departmental funds of WFIRM. The authors report no conflicts of interest.

Wake Forest Baptist Medical Center

Related Endothelial Cells Articles:

Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.
Scientists modify CAR-T cells to target multiple sites on leukemia cells
In a preclinical study, scientists engineer new CAR-T cells to attack three sites on leukemia cells, instead of one.
Sphingotec's endothelial function biomarker bio-ADM® improves risk stratification of sepsis patients at ICUs
New study data show that monitoring blood levels of sphingotec's endothelial function biomarker bio-ADM® on top of guideline parameter lactate improves risk stratification of sepsis patients admitted to intensive care units.
sphingotec's endothelial function biomarker bio-ADM® predicts need for organ support in general ICU patient population
Data from more than 2,000 patients enrolled in the FROG-ICU study demonstrate that high levels of bioactive adrenomedullin (bio-ADM®) predict the need for organ support, ionotropes, and vasopressors in the general patient population at admission to the intensive care unit (ICU).
First-of-its-kind study in endothelial stem cells finds exposure to flavored e-cigarette liquids, e-cigarette use exacerbates cell dysfunction
There has been a rapid rise in e-cigarette use, but its health effects have not been well-studied and their effect on vascular health remains unknown.
Dead cells disrupt how immune cells respond to wounds and patrol for infection
Immune cells prioritise the clearance of dead cells overriding their normal migration to sites of injury.
Transplanted bone marrow endothelial progenitor cells delay ALS disease progression
Transplanting human bone marrow-derived endothelial progenitor cells into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier, University of South Florida researchers report.
Revealed: How the 'Iron Man' of immune cells helps T cells fight infection
The immune system's killer T cells are crucial in fighting viral infections.
White blood cells related to allergies may also be harnessed to destroy cancer cells
A new Tel Aviv University study finds that white blood cells which are responsible for chronic asthma and modern allergies may be used to eliminate malignant colon cancer cells.
Resist! TAK1 enables endothelial cells to avoid apoptosis
TNFα-induced cell death is tightly regulated and resisted in endothelial cells.
More Endothelial Cells News and Endothelial Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at